Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 1/2 1Phase 1 1

Status

Completed 19Recruiting 9Unknown 6Terminated 6Not yet recruiting 6Active not recruiting 4Suspended 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Pancreatic Neoplasms 9Carcinoma, Non-Small-Cell Lung 7Rectal Neoplasms 6Colorectal Neoplasms 6Breast Neoplasms 6Neoplasms 5Glioblastoma 5Squamous Cell Carcinoma of Head and Neck 4Ovarian Neoplasms 4Head and Neck Neoplasms 4Stomach Neoplasms 3Oligodendroglioma 3Mouth Neoplasms 3Lung Neoplasms 3Glioma 3Esophageal Neoplasms 3Astrocytoma 3Urinary Bladder Neoplasms 2Sarcoma 2Neoplasm Metastasis 2Meningioma 2Melanoma 2Gliosarcoma 2Glioma, Subependymal 2Fallopian Tube Neoplasms 2Ependymoma 2Carcinoma, Squamous Cell 2Carcinoma, Ovarian Epithelial 2Adenocarcinoma Of Esophagus 2Xerostomia 1

Interventions

Capecitabine 35Oxaliplatin 32Fluorouracil 29Leucovorin 26Irinotecan 22Bevacizumab 19Cetuximab 17Radiotherapy 16Radiation 11Surgical Procedures, Operative 6Radiotherapy, Intensity-Modulated 5Gene Expression Profiling 5Chemotherapy, Adjuvant 5Celecoxib 5Neoadjuvant Therapy 4Immunohistochemistry 4Biopsy 4Amplified Fragment Length Polymorphism Analysis 4cediranib 3Reverse Transcriptase Polymerase Chain Reaction 3Receptor Protein-Tyrosine Kinases 3Folfox protocol 3Drug Therapy 3Cisplatin 3sargramostim 2regorafenib 2pembrolizumab 2fludarabine phosphate 2aldesleukin 2Surveys and Questionnaires 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Terminated × Rectal Neoplasms × Surgical Procedures, Operative × Clear all
NCT02910843 2023-01-10

RECAP

Swiss Cancer Institute

Phase 1 Terminated
25 enrolled
Gastrointestinal

Rectal Neoplasms

NCT02010567 2020-11-03

Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 1/2 Terminated
32 enrolled 18 charts
Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT03258541 2020-05-15

Organ-sparing With TraceIT® for Rectal Cancer Radiotherapy

University Hospital, Geneva

Phase NA Terminated
2 enrolled
Gastrointestinal

Rectal Neoplasms

NCT00081224 2016-12-15

Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum

Alliance for Clinical Trials in Oncology

Phase 2 Terminated
3 enrolled
Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT00216086 2016-06-06

Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer

Hoosier Cancer Research Network

Phase 2 Terminated
22 enrolled 10 charts
Gastrointestinal

Rectal Neoplasms

NCT00176787 2008-01-10

Radiation Therapy With Capecitabine in Rectal Cancer

University of Michigan Rogel Cancer Center

Phase 2 Terminated
30 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡